# Continued Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine

> **NCT00787826** · PHASE2 · UNKNOWN · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 1000 (estimated)

## Conditions studied

- Tularemia

## Interventions

- **BIOLOGICAL:** Live Francisella Tularensis Vaccine

## Key facts

- **NCT ID:** NCT00787826
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08-28
- **Primary completion:** 2019-11-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2021-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00787826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00787826, "Continued Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00787826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*